Loading cancer entity…
Loading cancer entity…
Variants & evidence
14 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CDK4 Amplification2 | ||||||||
| Palbociclib | Liposarcoma | Predictive | B | Supports Sensitivity Response | 3 | accepted | EID1366In a phase 2 clinical trial, NCT01209598, 30 patients with CDK4-amplified and RB-expressing well differentiated and dedifferentiated liposarcomas (WDLS/DDLS) were treated with a selective CDK 4/6 inhi… (full text at CIViC) PMID 23569312 · Dickson et al., 2013 · Open in CIViC | civic |
| 〃 | Liposarcoma | Predictive | B | Supports Sensitivity Response | 3 | accepted | EID4841A total of 59 patients with well-differentiated or dedifferentiated liposarcomas were enrolled in a phase 2 study to evaluate palbociclib efficacy. Half of the patients had received prior treatment an… (full text at CIViC) PMID 27124835 · Dickson et al., 2016 · Open in CIViC | civic |
| CTAG1B Expression1 | ||||||||
| Letetresgene Autoleucel | Myxoid Liposarcoma | Predictive | B | Supports Sensitivity Response | 3 | accepted | EID12573In the phase II trial (NCT02992743) of letetresgene autoleucel (lete-cel) in human leukocyte antigen ((HLA)-A*02:01–, HLA-A*02:05–, and/or HLA-A*02:06–positive), NY-ESO-1 (CTAG1B)-expressing advanced … (full text at CIViC) PMID 39836945 · D'Angelo et al., 2025 · Open in CIViC | civic |
| DDIT3 Fusion3 | ||||||||
| (diagnostic) | Liposarcoma | Diagnostic | B | Supports Positive | 3 | submitted | EID7982Both RT-PCR and PCR were used to detect and confirm the presence of fusion transcripts in RNA extracted from the surgical resections of 74 liposarcomas and 98 lipomas. EWSR1-DDIT3 (EWS-CHOP) was foun… (full text at CIViC) PMID 20332486 · Kubo et al., 2010 · Open in CIViC | civic |
| 〃 | Myxoid Liposarcoma | Diagnostic | C | Supports Positive | 3 | accepted | EID1778Identified two cases of myxoid liposarcoma with translocations (between 12q13 and 22q12) giving rise to EWSR1-DDIT3 (EWS-CHOP) fusions instead of the more common FUS-DDIT3. PMID 8637704 · Panagopoulos et al., 1996 · Open in CIViC | civic |
| 〃 | Dedifferentiated Liposarcoma | Diagnostic | C | Supports Positive | 1 | submitted | ||
| DDIT3 Fusion5 | ||||||||
| (diagnostic) | Liposarcoma | Diagnostic | B | Supports Positive | 4 | accepted | EID7981Both RT-PCR and PCR were used to detect and confirm the presence of fusion transcripts in RNA extracted from the surgical resections of 74 liposarcomas and 98 lipomas. FUS-DDIT3 (TLS-CHOP) was found … (full text at CIViC) PMID 20332486 · Kubo et al., 2010 · Open in CIViC | civic |
| 〃 | Myxoid Liposarcoma | Diagnostic | C | Supports Positive | 2 | accepted | EID1785In this 1992 paper, 9 of 26 liposarcoma patients had a histopathologic diagnosis of myxoid liposarcoma. Cytogenetic analysis revealed 6 of these patients had t(12;16)(q13;p11). 2 patients had a cyt… (full text at CIViC) PMID 1568170 · Sreekantaiah et al., 1992 · Open in CIViC | civic |
| 〃 | Myxoid Liposarcoma | Diagnostic | D | Supports Positive | 4 | accepted | ||
| LPP Fusion1 | ||||||||
| (diagnostic) | Liposarcoma | Diagnostic | B | Supports Negative | 4 | rejected | EID7984Both RT-PCR and PCR were used to detect and confirm the presence of fusion transcripts in RNA extracted from the surgical resections of 74 liposarcomas and 98 lipomas. HMGA2-LPP was found in 19/98 (19… (full text at CIViC) PMID 20332486 · Kubo et al., 2010 · Open in CIViC | civic |
| LPP Fusion + HMGA2 FusionHMGA2LPP1 | ||||||||
| (diagnostic) | Liposarcoma | Diagnostic | B | Supports Negative | 4 | accepted | EID7983Both RT-PCR and PCR were used to detect and confirm the presence of fusion transcripts in RNA extracted from the surgical resections of 74 liposarcomas and 98 lipomas. LPP-HMGA2 or HMGA2-LPP fusions w… (full text at CIViC) PMID 20332486 · Kubo et al., 2010 · Open in CIViC | civic |
| MDM2 Amplification1 | ||||||||
| HDM2 Inhibitor MK-8242 | Liposarcoma | Predictive | C | Supports Sensitivity Response | 4 | submitted | EID5518In 41 patients with postbaseline scans, three patients with liposarcoma achieved a partial response (at 250, 400, and 500 mg), 31 showed stable disease, and eight had progressive disease. In total, 27… (full text at CIViC) PMID 28240971 · Wagner et al., 2017 · Open in CIViC | civic |
Data updated 8 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.
Both RT-PCR and PCR were used to detect and confirm the presence of fusion transcripts in RNA extracted from the surgical resections of 74 liposarcomas and 98 lipomas. EWSR1::DDIT3 (EWS-CHOP) was foun… (full text at CIViC)
PMID 20332486 · Kubo et al., 2010 · Open in CIViC
| civic |
EID12430This study provided in vivo evidence showing the adipocyte-specific oncogenicity of the FUS::CHOP fusion transcript in liposarcoma, using a transgenic mouse model with ubiquitous FUS::CHOP expression … (full text at CIViC) PMID 10828883 · Pérez-Losada et al., 2000 · Open in CIViC |
| civic |
| 〃 | Myxoid Liposarcoma | Diagnostic | D | Supports Positive | 2 | accepted | EID12431This preclinical study examined the effect of the FUS::DDIT3 fusion protein on the oncogenic role of IGF-1R/PI3K/Akt signaling in myxoid liposarcoma (MLS) and explored the therapeutic potential of IGF… (full text at CIViC) PMID 28637688 · Trautmann et al., 2017 · Open in CIViC | civic |
| NVP-AEW541 | Myxoid Liposarcoma | Predictive | D | Supports Sensitivity Response | 3 | submitted | EID5920A comprehensive subset of myxoid liposarcoma specimens showed elevated expression and phosphorylation levels of various IGF-IR/PI3K/Akt signaling effectors. In HT1080 fibrosarcoma cells, overexpressio… (full text at CIViC) PMID 28637688 · Trautmann et al., 2017 · Open in CIViC | civic |